Evidence map›Paper›PMID 39597748›Full record

ArticleMicroorganisms2024

CMV Infection Risk Factors and Viral Dynamics After Valganciclovir Prophylaxis: 10 Years of Experience in Lung Transplant Recipients.

Sarela García-Masedo Fernández, Rosalía Laporta, Christian García Fadul, Myriam Aguilar Pérez, Jorge Anel Pedroche, Raquel Sanabrias Fernández de Sevilla, Ana Royuela, Isabel Sánchez Romero, María Piedad Ussetti Gil

Abstract read
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sarela García-Masedo FernándezMicrobiology Department, Hospital Universitario Puerta de Hierro, 28222 Majadahonda, Spain.
Rosalía LaportaPneumology Department, Hospital Universitario Puerta de Hierro, 28222 Majadahonda, Spain.
Christian García FadulPneumology Department, Hospital Universitario Puerta de Hierro, 28222 Majadahonda, Spain.
Myriam Aguilar PérezPneumology Department, Hospital Universitario Puerta de Hierro, 28222 Majadahonda, Spain.ORCID 0000-0002-3879-9298
Jorge Anel PedrocheMicrobiology Department, Hospital Universitario Puerta de Hierro, 28222 Majadahonda, Spain.ORCID 0009-0000-8065-4298
Raquel Sanabrias Fernández de SevillaPharmacy Department, Hospital Universitario Puerta de Hierro, 28222 Majadahonda, Spain.
Ana RoyuelaClinical Biostatistics Unit, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, 28222 Madrid, Spain.ORCID 0000-0003-1665-081X
Isabel Sánchez RomeroMicrobiology Department, Hospital Universitario Puerta de Hierro, 28222 Majadahonda, Spain.
María Piedad Ussetti GilPneumology Department, Hospital Universitario Puerta de Hierro, 28222 Majadahonda, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) The prevention of cytomegalovirus (CMV) in lung transplant recipients (LTx) is based on the administration of VGC for a period of 6-12 months, but there is little information on the premature discontinuation of the drug. Our objective was to evaluate the reasons for early cessation of VGC and the dynamics of CMV replication after discontinuation. (2) We carried out a retrospective study of LTx on VGC prophylaxis according to guidelines, with an outpatient follow-up period of >90 days. The detection of any level of CMV-DNA in the plasma (Cobas, Roche Diagnostics

Indexed as

cytomegalovirusdiscontinuationlungprophylaxistransplantvalganciclovir

Identifiers

PMID39597748
PMCPMC11596771

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.